• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微乳头型移行细胞癌的临床和病理特征:一种高度侵袭性的变体

Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant.

作者信息

Maranchie J K, Bouyounes B T, Zhang P L, O'Donnell M A, Summerhayes I C, DeWolf W C

机构信息

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Urol. 2000 Mar;163(3):748-51.

PMID:10687969
Abstract

PURPOSE

We present preliminary clinical, histochemical and molecular findings for 5 patients with micropapillary transitional cell carcinoma of the bladder, a rare histological variant not widely recognized in the urological literature.

MATERIALS AND METHODS

The 5 patients were prospectively identified. In 3 cases immunohistochemical staining for expression of CD31, p53, E-cadherin, and alpha, beta and gamma-catenin was performed on paraffin embedded tissue. Sequencing was used to identify point mutations in exons 5 to 9 of p53, and exons 1 and 2 of H-ras.

RESULTS

Of the patients 2 died within 1 year of presentation to our institution with rapid local extension along the bladder serosal surface and ureteral sheaths. Another patient had progression to invasive disease within 22 months. In the 3 cases with immunohistochemical staining p53 was negative, despite positive staining of nonmicropapillary transitional cell carcinoma within the same specimen. Stains for the angiotrophic marker CD31 were negative. In all 3 cases normal membrane associated alpha, beta and gamma-catenin expression was present. Examination of p53 sequences revealed a single point mutation in exon 8 of 1 case. In 2 cases different mutations in exon 1 of H-ras were noted.

CONCLUSIONS

Micropapillary transitional cell carcinoma is a rare and highly aggressive variant. Paradoxically, our study demonstrated no significant p53 abnormalities. The lacunar histological pattern did not appear to represent invasion of vascular spaces. Rather, these tumors seemed to have the ability to disrupt and replace the normal stromal matrix to achieve rapid nonendothelial extension. Thus, micropapillary histology may predict a lesser likelihood of surgical cure.

摘要

目的

我们展示了5例膀胱微乳头移行细胞癌患者的初步临床、组织化学和分子学研究结果,这是一种在泌尿学文献中未被广泛认识的罕见组织学变体。

材料与方法

前瞻性地确定了这5例患者。对3例患者的石蜡包埋组织进行了CD31、p53、E-钙黏蛋白以及α、β和γ连环蛋白表达的免疫组织化学染色。采用测序法鉴定p53外显子5至9以及H-ras外显子1和2中的点突变。

结果

在这些患者中,2例在就诊于我院1年内死亡,肿瘤沿膀胱浆膜表面和输尿管鞘迅速局部扩散。另1例患者在22个月内进展为浸润性疾病。在3例进行免疫组织化学染色的病例中,尽管同一标本中的非微乳头移行细胞癌呈阳性染色,但p53为阴性。血管生成标记物CD31染色为阴性。在所有3例病例中,均存在正常的膜相关α、β和γ连环蛋白表达。对p53序列的检测发现1例患者外显子8有一个单点突变。在2例病例中,注意到H-ras外显子1有不同的突变。

结论

微乳头移行细胞癌是一种罕见且侵袭性很强的变体。矛盾的是,我们的研究未发现明显的p53异常。腔隙性组织学模式似乎并不代表血管间隙浸润。相反,这些肿瘤似乎有能力破坏并取代正常的基质,以实现快速的非内皮性扩展。因此,微乳头组织学可能预示手术治愈的可能性较小。

相似文献

1
Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant.微乳头型移行细胞癌的临床和病理特征:一种高度侵袭性的变体
J Urol. 2000 Mar;163(3):748-51.
2
Invasive micropapillary urothelial carcinoma of the bladder.膀胱浸润性微乳头状尿路上皮癌。
Hum Pathol. 2010 Aug;41(8):1159-64. doi: 10.1016/j.humpath.2009.11.018. Epub 2010 Apr 8.
3
Micropapillary transitional cell carcinoma of the urinary bladder: report of two cases.膀胱微乳头移行细胞癌:2例报告
Pathologica. 2005 Oct;97(5):338-40.
4
Micropapillary bladder carcinoma: a clinicopathological study of 20 cases.微乳头型膀胱癌:20例临床病理研究
J Urol. 1999 Jun;161(6):1798-802. doi: 10.1016/s0022-5347(05)68807-6.
5
[Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].膀胱移行细胞癌中P21、P185、p53蛋白表达及ras、p53基因变异的检测及其临床病理意义
Zhonghua Bing Li Xue Za Zhi. 1996 Aug;25(4):202-5.
6
p53 Gene mutations in superficial bladder cancer.浅表性膀胱癌中的p53基因突变
Urol Int. 2004;73(3):212-8. doi: 10.1159/000080830.
7
Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.肌层浸润性膀胱移行细胞癌患者p53蛋白的结构改变
J Urol. 2001 Dec;166(6):2155-60.
8
p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.膀胱移行细胞癌中的p53突变与bcl-2表达
Zhonghua Yi Xue Za Zhi (Taipei). 2001 Jan;64(1):9-14.
9
Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.膀胱尿路上皮癌微乳头变型:一项临床病理及免疫组化研究
Histopathology. 2004 Jul;45(1):55-64. doi: 10.1111/j.1365-2559.2004.01895.x.
10
Immunohistochemical, molecular, and clinicopathological analyses of urothelial carcinoma, micropapillary variant.尿路上皮癌微乳头型的免疫组化、分子和临床病理分析。
Pathol Int. 2011 Dec;61(12):723-30. doi: 10.1111/j.1440-1827.2011.02731.x. Epub 2011 Oct 3.

引用本文的文献

1
The optimal management of variant histology in muscle invasive bladder cancer.肌层浸润性膀胱癌中变异组织学的最佳管理
Transl Androl Urol. 2020 Dec;9(6):2965-2975. doi: 10.21037/tau.2020.01.02.
2
Prognostic and therapeutic role of HER2 expression in micropapillary carcinoma of the bladder.HER2表达在膀胱微乳头癌中的预后及治疗作用
Mol Clin Oncol. 2019 Feb;10(2):205-213. doi: 10.3892/mco.2018.1786. Epub 2018 Dec 7.
3
Characteristics and clinical significance of histological variants of bladder cancer.膀胱癌的组织学变异特征及临床意义。
Nat Rev Urol. 2017 Nov;14(11):651-668. doi: 10.1038/nrurol.2017.125. Epub 2017 Sep 12.
4
High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection.一名感染BK病毒的肾移植受者发生的高级别尿路上皮癌。
NDT Plus. 2009 Jun;2(3):246-9. doi: 10.1093/ndtplus/sfp025. Epub 2009 Feb 26.
5
Expression of RCAS1 correlates with urothelial bladder cancer malignancy.RCAS1的表达与膀胱尿路上皮癌的恶性程度相关。
Int J Mol Sci. 2015 Feb 10;16(2):3783-803. doi: 10.3390/ijms16023783.
6
Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.根治性膀胱切除术后及辅助铂类化疗后伴有微乳头变异型的晚期肌层浸润性膀胱癌的肿瘤学结局
World J Urol. 2015 Aug;33(8):1087-93. doi: 10.1007/s00345-014-1387-1. Epub 2014 Sep 2.
7
Impact of density of schistosomal antigen expression in urinary bladder tissue on the stratification, cell type, and staging, and prognosis of carcinoma of the bladder in Egyptian patients.埃及患者膀胱癌组织中血吸虫抗原表达密度对膀胱癌分层、细胞类型和分期及预后的影响。
Infect Agent Cancer. 2014 Jun 26;9:21. doi: 10.1186/1750-9378-9-21. eCollection 2014.
8
Micropapillary bladder cancer: current treatment patterns and review of the literature.微乳头型膀胱癌:当前的治疗模式及文献综述
Urol Oncol. 2014 Aug;32(6):826-32. doi: 10.1016/j.urolonc.2014.01.020. Epub 2014 Jun 13.
9
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.膀胱 T1 微乳头状尿路上皮癌患者的临床转归。
J Urol. 2014 Sep;192(3):702-7. doi: 10.1016/j.juro.2014.02.2565. Epub 2014 Mar 3.
10
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database.低级别微乳头状尿路上皮癌是否存在?——监测、流行病学和最终结果(SEER)数据库的管理和结果分析。
J Cancer. 2013 May 6;4(4):336-42. doi: 10.7150/jca.6215. Print 2013.